[NRIX] YoY Annual Result on 30-Nov-2018 [#FY]

Stock
[NRIX] Nurix Therapeutics, Inc.
Announcement Date
30-Nov-2018
Financial Year
2018
Quarter
30-Nov-2018 [#FY]
Profit Trend
YoY-
Quarter Report
NRIX's Result
NRIX's Financial Summary
View:
Show?
Annual Result
30/11/23 30/11/22 30/11/21 30/11/20 30/11/19 30/11/18 CAGR
Revenue 76,987 38,627 29,750 17,820 31,115 37,449 15.49%
PBT -143,948 -180,360 -117,063 -63,777 -21,460 -8,921 74.35%
Tax 0 -14,315 131 -20,535 239 507 -
NP -143,948 -166,045 -117,194 -43,242 -21,699 -9,428 72.43%
Tax Rate - - - - - - -
Total Cost 220,935 204,672 146,944 61,062 52,814 46,877 36.32%
Ratio Analysis
30/11/23 30/11/22 30/11/21 30/11/20 30/11/19 30/11/18 CAGR
NP Margin -186.98 -429.87 -393.93 -242.66 -69.74 -25.18 49.29%
Per Share
30/11/23 30/11/22 30/11/21 30/11/20 30/11/19 30/11/18 CAGR
EPS -2.65 -3.42 -2.73 -2.76 -0.56 -0.59 35.02%
EPS Diluted -2.65 -3.42 -2.73 -2.76 -0.56 -0.59 35.02%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.